Home/ Stocks/ DYAI

Dyadic International, Inc.

DYAI XNAS

$1.00 -0.02 (-1.96%) ▼ 15-min delayed

Open

$1.02

High

$1.05

Low

$0.97

Volume

89.0K

Market Cap

$37.17M

About Dyadic International, Inc.

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 5 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$1.11M	$-1,954,683	$-0.05
FY 2025	$3.09M	$-7,364,628	$-0.23
Q3 2025	$1.16M	$-1,976,012	$-0.06
Q1 2025	$393.6K	$-2,027,579	$-0.07

Related Market News

No specific coverage for DYAI yet. Check out our latest market news or earnings calendar.

Get DYAI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Dyadic International, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.